These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

685 related items for PubMed ID: 11038002

  • 1. Peptide receptor imaging and therapy.
    Kwekkeboom D, Krenning EP, de Jong M.
    J Nucl Med; 2000 Oct; 41(10):1704-13. PubMed ID: 11038002
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Radiolabeled somatostatin analog scintigraphy in oncology and immune diseases: an overview.
    Kwekkeboom DJ, Krenning EP.
    Eur Radiol; 1997 Oct; 7(7):1103-9. PubMed ID: 9265684
    [Abstract] [Full Text] [Related]

  • 5. Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.
    Kwekkeboom DJ, Kam BL, van Essen M, Teunissen JJ, van Eijck CH, Valkema R, de Jong M, de Herder WW, Krenning EP.
    Endocr Relat Cancer; 2010 Mar; 17(1):R53-73. PubMed ID: 19995807
    [Abstract] [Full Text] [Related]

  • 6. Tumor imaging and therapy using radiolabeled somatostatin analogues.
    de Jong M, Breeman WA, Kwekkeboom DJ, Valkema R, Krenning EP.
    Acc Chem Res; 2009 Jul 21; 42(7):873-80. PubMed ID: 19445476
    [Abstract] [Full Text] [Related]

  • 7. Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues.
    De Jong M, Breeman WA, Bernard HF, Kooij PP, Slooter GD, Van Eijck CH, Kwekkeboom DJ, Valkema R, Mäcke HR, Krenning EP.
    Q J Nucl Med; 1999 Dec 21; 43(4):356-66. PubMed ID: 10731786
    [Abstract] [Full Text] [Related]

  • 8. Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.
    De Jong M, Valkema R, Jamar F, Kvols LK, Kwekkeboom DJ, Breeman WA, Bakker WH, Smith C, Pauwels S, Krenning EP.
    Semin Nucl Med; 2002 Apr 21; 32(2):133-40. PubMed ID: 11965608
    [Abstract] [Full Text] [Related]

  • 9. Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy.
    Krenning EP, de Jong M, Kooij PP, Breeman WA, Bakker WH, de Herder WW, van Eijck CH, Kwekkeboom DJ, Jamar F, Pauwels S, Valkema R.
    Ann Oncol; 1999 Apr 21; 10 Suppl 2():S23-9. PubMed ID: 10399029
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of 111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients: biodistribution, kinetics, organ and tumor uptake.
    Kwekkeboom DJ, Kooij PP, Bakker WH, Mäcke HR, Krenning EP.
    J Nucl Med; 1999 May 21; 40(5):762-7. PubMed ID: 10319747
    [Abstract] [Full Text] [Related]

  • 12. Somatostatin receptor-targeted radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors.
    Kwekkeboom DJ, de Herder WW, Krenning EP.
    Endocrinol Metab Clin North Am; 2011 Mar 21; 40(1):173-85, ix. PubMed ID: 21349418
    [Abstract] [Full Text] [Related]

  • 13. DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy.
    Otte A, Jermann E, Behe M, Goetze M, Bucher HC, Roser HW, Heppeler A, Mueller-Brand J, Maecke HR.
    Eur J Nucl Med; 1997 Jul 21; 24(7):792-5. PubMed ID: 9211767
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives.
    Breeman WA, de Jong M, Kwekkeboom DJ, Valkema R, Bakker WH, Kooij PP, Visser TJ, Krenning EP.
    Eur J Nucl Med; 2001 Sep 21; 28(9):1421-9. PubMed ID: 11585303
    [Abstract] [Full Text] [Related]

  • 16. OctreoTher: ongoing early clinical development of a somatostatin-receptor-targeted radionuclide antineoplastic therapy.
    Smith MC, Liu J, Chen T, Schran H, Yeh CM, Jamar F, Valkema R, Bakker W, Kvols L, Krenning E, Pauwels S.
    Digestion; 2000 Sep 21; 62 Suppl 1():69-72. PubMed ID: 10940690
    [Abstract] [Full Text] [Related]

  • 17. New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.
    Virgolini I, Traub T, Leimer M, Novotny C, Pangerl T, Ofluoglu S, Halvadjieva E, Smith-Jones P, Flores J, Li SR, Angelberger P, Havlik E, Andreae F, Raderer M, Kurtaran A, Niederle B, Dudczak R.
    Q J Nucl Med; 2000 Mar 21; 44(1):50-8. PubMed ID: 10932601
    [Abstract] [Full Text] [Related]

  • 18. Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours.
    Slooter GD, Mearadji A, Breeman WA, Marquet RL, de Jong M, Krenning EP, van Eijck CH.
    Br J Surg; 2001 Jan 21; 88(1):31-40. PubMed ID: 11136306
    [Abstract] [Full Text] [Related]

  • 19. Radio-guided surgery in neuroendocrine tumors.
    Gulec SA, Baum R.
    J Surg Oncol; 2007 Sep 15; 96(4):309-15. PubMed ID: 17726664
    [Abstract] [Full Text] [Related]

  • 20. Radiopharmaceuticals used for diagnosis and therapy of NETs.
    Papachristou M.
    Hell J Nucl Med; 2023 Sep 15; 26 Suppl():19-20. PubMed ID: 37658556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.